CERS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CERS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-27), Cerus's current share price is $1.71. Cerus's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.66. Cerus's Cyclically Adjusted PS Ratio for today is 2.59.
The historical rank and industry rank for Cerus's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Cerus's highest Cyclically Adjusted PS Ratio was 14.94. The lowest was 1.95. And the median was 8.35.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Cerus's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.258. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.66 for the trailing ten years ended in Dec. 2023.
The historical data trend for Cerus's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cerus Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 5.82 | 4.68 | 3.82 | 2.49 | 3.28 |
For the Medical Devices subindustry, Cerus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Cerus's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Cerus's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Cerus's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 1.71 | / | 0.66 | |
= | 2.59 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cerus's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:
For example, Cerus's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 0.258 | / | 129.4194 | * | 129.4194 | |
= | 0.258 |
Current CPI (Dec. 2023) = 129.4194.
Cerus Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201403 | 0.105 | 99.695 | 0.136 |
201406 | 0.115 | 100.560 | 0.148 |
201409 | 0.136 | 100.428 | 0.175 |
201412 | 0.120 | 99.070 | 0.157 |
201503 | 0.081 | 99.621 | 0.105 |
201506 | 0.092 | 100.684 | 0.118 |
201509 | 0.082 | 100.392 | 0.106 |
201512 | 0.098 | 99.792 | 0.127 |
201603 | 0.077 | 100.470 | 0.099 |
201606 | 0.091 | 101.688 | 0.116 |
201609 | 0.099 | 101.861 | 0.126 |
201612 | 0.098 | 101.863 | 0.125 |
201703 | 0.068 | 102.862 | 0.086 |
201706 | 0.091 | 103.349 | 0.114 |
201709 | 0.098 | 104.136 | 0.122 |
201712 | 0.142 | 104.011 | 0.177 |
201803 | 0.109 | 105.290 | 0.134 |
201806 | 0.117 | 106.317 | 0.142 |
201809 | 0.115 | 106.507 | 0.140 |
201812 | 0.121 | 105.998 | 0.148 |
201903 | 0.128 | 107.251 | 0.154 |
201906 | 0.132 | 108.070 | 0.158 |
201909 | 0.128 | 108.329 | 0.153 |
201912 | 0.146 | 108.420 | 0.174 |
202003 | 0.118 | 108.902 | 0.140 |
202006 | 0.131 | 108.767 | 0.156 |
202009 | 0.142 | 109.815 | 0.167 |
202012 | 0.168 | 109.897 | 0.198 |
202103 | 0.138 | 111.754 | 0.160 |
202106 | 0.184 | 114.631 | 0.208 |
202109 | 0.210 | 115.734 | 0.235 |
202112 | 0.230 | 117.630 | 0.253 |
202203 | 0.215 | 121.301 | 0.229 |
202206 | 0.232 | 125.017 | 0.240 |
202209 | 0.223 | 125.227 | 0.230 |
202212 | 0.248 | 125.222 | 0.256 |
202303 | 0.174 | 127.348 | 0.177 |
202306 | 0.215 | 128.729 | 0.216 |
202309 | 0.220 | 129.860 | 0.219 |
202312 | 0.258 | 129.419 | 0.258 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Cerus's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Eric Bjerkholt | director | 132 PURDURE AVENUE, KENGSINGTON CA 94708 |
Ann Lucena | director | C/O CERUS CORPORATION, 1220 CONCORD AVE. SUITE 600, CONCORD CA 94520 |
Swisher Daniel N Jr | director | C/O SUNESIS PHARMACEUTICALS, INC., 395 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO CA 94080 |
Gail Schulze | director | 3451 WELLS ROAD, MALVERN PA 19355 |
Laurence M Corash | director | C/O CERUS CORP, 2411 STENWELL DRIVE, CONCORD CA 94520 |
William Mariner Greenman | officer: President, Cerus Europe | C/O CERUS CORPORATION, 2411 STANWELL DRIVE, CONCORD CA 94520 |
Chrystal Menard | officer: Chief Legal Officer | C/O CERUS CORPORATION, 2550 STANWELL DRIVE, CONCORD CA 94520 |
Kevin Dennis Green | officer: Chief Accounting Officer | C/O CERUS CORPORATION, 2411 STANWELL DRIVE, CONCORD CA 94520 |
Richard J Benjamin | officer: Chief Medical Officer | 15 WHITE PINE ROAD, NEWTON MA 02464 |
Vivek K Jayaraman | officer: Chief Commercial Officer | 3910 BRICKWAY BLVD, SANTA ROSA CA 95403 |
Hua Shan | director | C/O CERUS CORPORATION, 1220 CONCORD AVE., STE. 600, CONCORD CA 94520 |
Carol Moore | officer: SR. V.P. Regulatory, Clinical | C/O CERUS CORPORATION, 2550 STANWELL DRIVE, CONCORD CA 94520 |
Timothy B Anderson | director | C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015 |
Timothy L. Moore | director | C/O KITE PHARMA, INC., 2225 COLORADO AVE., SANTA MONICA CA 90404 |
Frank Witney | director | 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451 |
From GuruFocus
By Business Wire Business Wire • 01-09-2023
By Business Wire Business Wire • 07-05-2022
By Business Wire Business Wire • 05-03-2022
By Business Wire Business Wire • 01-10-2022
By Business Wire Business Wire • 04-20-2023
By Business Wire Business Wire • 04-21-2022
By Business Wire Business Wire • 06-05-2023
By Business Wire Business Wire • 11-02-2022
By Business Wire Business Wire • 02-10-2023
By Business Wire Business Wire • 07-21-2022